
- Moving the market
The Dow briefly tagged a new record high early on as traders kept rotating out of tech and into more economy-sensitive names.
The broader market had a mixed day, but the tone felt like “value and cyclical stocks are back in play” after recent weakness.
In healthcare, Merck jumped more than 3% (and was the Dow’s biggest gainer at +3.5%) after crushing Q4 earnings and revenue on strong demand for its cancer immunotherapy and other products.
Pepsi added about 4% on solid organic sales growth across the board. Banks joined the party too—JPMorgan and Wells Fargo up around 2% each, Citigroup gaining about 1%.
Palantir popped 6% on strong Q4 results and upbeat guidance.
On the flip side, most tech names were in the red. Nvidia and Microsoft each shed 2%, adding to their rough start to 2026. Software stocks continued struggling—ServiceNow -7%, Salesforce -5%.
The big support came from metals: gold and silver each surged over 6%, copper ripped almost 4.5%. That helped offset the equity weakness.
The Mag 7 massively underperformed the rest of the S&P 493 again, with the majors closing mostly red (Nasdaq led the downside). Only small caps found enough juice to eke out a green finish.
Bond yields ended lower after an early spike, the dollar mirrored that softness, Bitcoin went nowhere (dipped to ~$73K but bounced back toward $76K), and silver was the most volatile — spiking 12% at one point before settling back.
Historically, February is the second-weakest month of the year—mid-month gains often vanish by the end. Will that pattern repeat this time around?
Read More




